Acquisitions6 Jun 2024, 11:13 pm
Alkem Laboratories to Invest Rs. 30 Crores in HaystackAnalytics Private Limited
AI Summary
Alkem Laboratories Ltd. has agreed to invest an amount of Rs. 30,00,05,156/- in the (Pre-Series A) Compulsorily Convertible Preference Shares of M/s HaystackAnalytics Private Limited. This strategic investment will help Alkem Laboratories to participate in the growing diagnostic space and leverage Haystack's expertise in advanced genomic data analysis. The acquisition does not fall under related party transaction and the cost of acquisition is Rs. 30,00,05,156/-. Alkem Laboratories will acquire 7.42% (16,654) shares in HaystackAnalytics Private Limited.
Key Highlights
- Alkem Laboratories to invest Rs. 30 crores in HaystackAnalytics Private Limited
- Investment is a strategic move to participate in the growing diagnostic space
- Alkem to leverage Haystack's expertise in advanced genomic data analysis
- Acquisition does not fall under related party transaction
- Alkem to acquire 7.42% (16,654) shares in HaystackAnalytics Private Limited